High Flow Nasal Cannula and Mask Oxygenation in Patients With Visceral Obesity Undergoing Sedated Gastroscopy
NCT ID: NCT07159022
Last Updated: 2025-12-01
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
200 participants
INTERVENTIONAL
2025-08-31
2026-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Increasing evidence supports the use of High-flow nasal cannula (HFNC) oxygenation in obese patients during sedated gastrointestinal endoscopy. Obesity, especially visceral obesity, is an established risk factor associated with all-cause mortality. Body roundness index (BRI) is a newer anthropometric measure associated with identification of high-risk individuals. Owing to the limited evidence, we designed this unblinded randomized controlled trial to assess whether HFNC, compared to standard mask oxygenation, improves oxygenation at the end of the procedure (primary endpoint) in patients with visceral obesity.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Gastric Insufflation During Positive Pressure Ventilation
NCT04964882
Gastric Volume in Paralyzed Obese Patients After High-flow Nasal Oxygen Therapy
NCT06216912
Endoscopic Gastric Reduction for Weight Management
NCT01682733
Application of New Oropharyngeal Airway Management in Obese Patients Undergoing Painless Gastroenteroscopy
NCT06590922
Magnetically Controlled Capsule Endoscope System in Stomach Examination of Moderately and Severely Obese Patients
NCT05459714
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
High Flow Nasal Cannula Oxygenation
High Flow Nasal cannula is a system to deliver heated and humidified oxygen with an inspired oxygen fraction between 21 and 100% through large bore nasal cannula. The system delivers a flow up to 60 liters/min.
High Flow Nasal Cannula Oxygenation
High Flow Nasal Cannula will be set at 60 liters per minute of air/oxygen admixture to reach a peripheral oxygen saturation equal or greater than 94%
Mask Oxygenation
Conventional Oxygenation will be administered through mask
Face Mask Oxygenation
conventional oxygen therapy will be administered through common mask with a flow up to 6 Liters per minute
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
High Flow Nasal Cannula Oxygenation
High Flow Nasal Cannula will be set at 60 liters per minute of air/oxygen admixture to reach a peripheral oxygen saturation equal or greater than 94%
Face Mask Oxygenation
conventional oxygen therapy will be administered through common mask with a flow up to 6 Liters per minute
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Visceral obesity(body mass index≥28 and BRI ≥5.46)
* Patients who will undergo sedated gastroscopy
Exclusion Criteria
* Presence of pneumothorax or pulmonary bullae, pulmonary embolism, pulmonary oedema
* Upper respiratory tract infection
* Presence of tracheostomy
* Nasal or nasopharyngeal diseases
* Coagulation disorders or a tendency of nose bleeding
* Pregnancy
* Recent (within 1 week) thoracic surgery
* Emergent procedure or surgery
* Allergy to drugs used during the procedure
* Unwillingness to participate in the study
18 Years
80 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Shanghai Zhongshan Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Zhongshan Hospitla
Shanghai, , China
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
B2025-212
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.